BIM
WINT

BlackRock Investment Management’s Windtree Therapeutics Inc WINT Stock Holding History

BlackRock Investment Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,025
Closed -$17K – 4248
2015
Q1 		$17K Buy
1,025
+7
+0.7% +$138 ﹤0.01% 3495
2014
Q4 		$17K Hold
1,018
– – ﹤0.01% 3500
2014
Q3 		$26K Buy
1,018
+29
+3% +$700 ﹤0.01% 3365
2014
Q2 		$25K Buy
+989
New +$25.3K ﹤0.01% 3357

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock Investment Management's WINT Position: Q2 2015 in Review

BlackRock Investment Management sold out of Windtree Therapeutics Inc (WINT) in Q2 2015, closing a stake of 1,025 shares — an estimated $17K sold.

BlackRock Investment Management first reported a position in WINT in Q2 2014 and held it in 4 quarters. The position peaked at $26K in Q3 2014. 52 funds tracked by Wall St. Rank hold WINT as of Q2 2015.

  • BlackRock Investment Management reported no remaining Windtree Therapeutics Inc position as of Q2 2015 after selling out during the quarter.
  • BlackRock Investment Management sold 1,025 Windtree Therapeutics Inc shares in Q2 2015, an estimated $17K.
  • BlackRock Investment Management first reported a position in Windtree Therapeutics Inc in Q2 2014 and held it in 4 quarters.
  • BlackRock Investment Management's Windtree Therapeutics Inc position peaked at $26K in Q3 2014.
  • 52 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2015.

Based on BlackRock Investment Management's 13F filing for Q2 2015, filed 7 Aug 2015.